Application of Glucocorticoids in Therapy of Multiple Sclerosis
DOI:
https://doi.org/10.53933/sspmpm.v4i2.141Keywords:
multiple sclerosis, glucocorticoid therapy, exacrbation, secondary progression, uncertain prognosisAbstract
Multiple sclerosis is an autoimmune disease affecting the central nervous system that causes significant disability and healthcare burden. Pulse-dosaged glucocorticoids therapy remains the mainstay of treatment of exacerbations of multiple sclerosis. A total of 98 patients were examined, including 28 patients with relapsing-remitting multiple sclerosis (24 women and 4 men) and 70 patients with secondary progressive multiple sclerosis (57 women and 13 men). The number of glucocorticoids therapy courses in 98 patients at all disease stages totalled 536: 98 in relapsing-remitting multiple sclerosis (9 at debuts and 89 at relapsing-remitting stage) and 438 in secondary progredient multiple sclerosis (11 at debuts, 178 at relapsing-remitting stage, and 249 at secondary progression stage). The efficacy of repeated courses of glucocorticoids therapy in patients with RR and secondary progredient multiple sclerosis was evaluated at different stages of the disease progression: debut in relapsing-remitting and secondary progredient multiple sclerosis, relapsing-remitting stage in relapsing-remitting and secondary progredient multiple sclerosis, and secondary progression stage in secondary progredient multiple sclerosis, including retrospective analysis. Important conclusions have been made about complex systemic reorganisation at different stages of relapsing-remitting and secondary-progredient types of multiple sclerosis, efficiency of glucocorticoids therapy in different types of multiple sclerosis and stages of pathological process and about influence of glucocorticoids therapy on the prognosis of the disease.
References
Gusev E.I., Boiko A.N. Multiple sclerosis: from studying immunopathogenesis to new treatment techniques. M.: Gubernskaya Medicine, 2001. 128 p.
Gusev E.I., Zavalishin I.A., Noiko A.N. Multiple sclerosis and other demyelinating diseases. M.: Miklosh, 2004. 540 p.
Levin O.S. Immunotherapy of multiple sclerosis. Russian Medical Journal. 2001. No.6. P.48-52.
Yevtushenko S.K., Derevyanko I.N. Current approaches to the treatment of multiple sclerosis: achievements, disappointments, hopes (2nd communication). International Neurological Journal. 2006. No.2 (6). P.2–12.
Compston A. The pathogenesis and basis for treatment in multiple sclerosis. Clin. Neurol. Neurosurg. 2004. Vol.106. No.3. P.246-248. URL: https://pubmed.ncbi.nlm.nih.gov/15177777/
Dobson R., Giovannoni G. Multiple sclerosis – a review. Еuropean Journal of Neurology. 2018. Vol.26. No.1. P.27–40. URL: https://doi.org/10.1111/ene.13819
Voloshyna N.P., Taitslin V.I., A. H. Leshchenko A.H. et al. Multiple sclerosis in Ukraine: prevalence, course, prognosis, treatment, pharmacoeconomics. Ukrainian Bulletin of Psychoneurology. 2007. Vol.15, Iss. 1(50). P. 6–21.
Voloshyn P.V., Voloshyna N.P., Taitslin V.I. et al. Current aspects of multiple sclerosis: pathogenesis, peculiarities of disease course in Ukraine, diagnosis, standards of pathogenetic therapy. Neuron-Review (Journal of Clinical Neurosciences). 2007. No. 3. P. 4-26.
Tarianyk K.A., Shkodina A.D., Lytvynenko N.V. et al. Combined therapy of relapsing-remitting multiple sclerosis exacerbations with plasmapheresis and glucocorticoids with regard to patients’ quality of life. Ukrainian Neurological Journal. 2020. No. 3. P. 29–34. doi 0.30978/UNJ2020-3-29. URL: http://ukrneuroj.com.ua/article/view/UNJ2020-3-29
Voloshyna N.P., Nehreba T.V., Vasylosvkyy V.V. et al. Comparative efficacy of hormonal pulse therapy in relapsing-remitting and secondary-progressive types of multiple sclerosis with different prognosis patterns. Communication I. Efficacy of hormonal pulse therapy in the debut and relapsing phase in relapsing and secondary-progressive types of multiple sclerosis with different prognosis patterns. International Neurological Journal. 2018. No. 4(98). P. 21–31. URL: http://www.mif-ua.com/archive/article/46247
Voloshyna N.P., Nehreba T.V., Vasylosvkyy V.V. Comparative efficacy of hormonal pulse therapy in relapsing-remitting and secondary-progressive types of multiple sclerosis with different prognosis patterns. Communication II. Efficacy of hormonal pulse therapy in the progression phase in the secondary-progressive type of multiple sclerosis with different prognosis patterns. International Neurological Journal. 2018. No. 7(101). P. 14–16.
Douglas S., Hudin H. Glucocorticoids for the treatment of multiple sclerosis. Handb Clin Neurol. 2014. No.122. Р. 455–464. doi: 10.1016/B978-0-444-52001-2.00020-0. URL: https://pubmed.ncbi.nlm.nih.gov/24507531/
Sharrack B., Hughes R., R. Morris R. et al. The effect of oral and intravenous methylprednisolone treatment on subsequent relapse rate in multiple sclerosis. J. Neurol. Sci. 2000. Vol.1. No.173(1). P.73–77. URL: https://pubmed.ncbi.nlm.nih.gov/10675582/
Alam S.M., Kyriakides T.M., Lawdwn P.K. Newman methylprednisolone in multiple sclerosis. J. Neurol. 2008. No.56. P. 1219–1220.
Voloshyna N. P., Vasylovskyy V.V., Chernenko M.Ye. Use of mitoxantrone in combination with cortexin for the treatment of progressive multiple sclerosis. International Neurological Journal. 2008. No. 6(22). P. 13–16. URL: http://www.mif-ua.com/archive/article/7508
Vasylovskyy V.V., Voloshyna N.P., Nehreba T.V. et al. Efficacy of mitoxantrone in patients with progredient types of multiple sclerosis. International Neurological Journal. 2015. No. 7(77). P. 17–27.
Poser Ch. Multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 1993. No. 4. P. 77–78.
Zavalishin I.A., Zakharova M.N., Peresadova A.V. et al. Progressive course of multiple sclerosis. S.S. Korsakov Journal of Neuropathology and Psychiatry. 2002. No. 2, special issue. P. 26–31.
Nehreba T.V. Comparative clinical characteristics of debuts and relapse stages in relapsing-remitting and secondary-progressive multiple sclerosis. Ukrainian Bulletin of Psychoneurology. 2004. Vol. 12. Iss. 1 (38). P. 66–69.
Nehreba T.V. Course and prognosis of modern forms of multiple sclerosis. Ukrainian Bulletin of Psychoneurology. 2006. Vol. 14. Iss. 1(46). P. 44–46.
Copyright for a scientific work No.47786 dated 13.02.2013. Voloshyna N.P., Vasylovskyy V.V., Levchenko I.L. et al. New approaches to the clinical diagnosis of different types of multiple sclerosis and their differentiated therapy. Practical recommendations.
Copyright for a scientific work No.39160 dated 14.07.2011. Nehreba T.V. Prognostic criteria for different types of multiple sclerosis.
Voloshyna N.P., Nehreba T.V., Vasylovskyy V.V. et al. Development of prognosis depending on the development of the progression stage and progression options in progressive types of multiple sclerosis. Ukrainian Bulletin of Psychoneurology. 2021. Vol. 29. Iss.3(108). P. 18–22.
Voloshyna N.P., Nehreba T.V., Vasylovskyy V.V. et al. Clinical and mathematical analysis of relationships between prognosis and debut patterns in different types of multiple sclerosis. Georgian medical news. 2021. No.9(318). P. 127–133.
Voloshyna N.P., Vasylovskyy V.V., Kirzhner V.M. et al. Correlation analysis between clinical parameters in different types of multiple sclerosis. Ukrainian Bulletin of Psychoneurology. 2022. Vol.30. Iss.1(110). P. 21–27. doi: https://doi.org/10.36927/2079-0325-V30-is3-2022-94
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Vitaliy Vasylovskyy , Tetiana Nehreba, Nataliya Voloshyna, Maksym Chernenko, Tetiana Pohulaieva
This work is licensed under a Creative Commons Attribution 4.0 International License.
